Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genprex (GNPX) Gains from Sales and Divestitures (2024 - 2025)

Genprex (GNPX) has 2 years of Gains from Sales and Divestitures data on record, last reported at $1785.0 in Q3 2025.

  • For Q3 2025, Gains from Sales and Divestitures rose 181.99% year-over-year to $1785.0; the TTM value through Sep 2025 reached $1785.0, up 181.99%, while the annual FY2024 figure was $31623.0, N/A changed from the prior year.
  • Gains from Sales and Divestitures reached $1785.0 in Q3 2025 per GNPX's latest filing, down from $89230.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $89230.0 in Q2 2025 and bottomed at $633.0 in Q3 2024.